AMRX
Price
$7.81
Change
-$0.36 (-4.41%)
Updated
Apr 3 closing price
Capitalization
1.87B
28 days until earnings call
BHC
Price
$5.24
Change
-$0.43 (-7.58%)
Updated
Apr 4, 11:06 AM (EDT)
Capitalization
3.86B
26 days until earnings call
Ad is loading...

AMRX vs BHC

Header iconAMRX vs BHC Comparison
Open Charts AMRX vs BHCBanner chart's image
Amneal Pharmaceuticals
Price$7.81
Change-$0.36 (-4.41%)
Volume$1.99M
Capitalization1.87B
Bausch Health Companies
Price$5.24
Change-$0.43 (-7.58%)
Volume$5.98K
Capitalization3.86B
AMRX vs BHC Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. BHC commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a StrongBuy and BHC is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AMRX: $7.81 vs. BHC: $5.67)
Brand notoriety: AMRX: Not notable vs. BHC: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 118% vs. BHC: 89%
Market capitalization -- AMRX: $1.87B vs. BHC: $3.86B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. BHC’s [@Pharmaceuticals: Other] market capitalization is $3.86B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileBHC’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • BHC’s FA Score: 1 green, 4 red.
According to our system of comparison, AMRX is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while BHC’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 5 bearish.
  • BHC’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than BHC.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -5.51% price change this week, while BHC (@Pharmaceuticals: Other) price change was -16.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.00%. For the same industry, the average monthly price growth was -2.21%, and the average quarterly price growth was -10.30%.

Reported Earning Dates

AMRX is expected to report earnings on May 02, 2025.

BHC is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($3.86B) has a higher market cap than AMRX($1.87B). AMRX has higher P/E ratio than BHC: AMRX (90.00) vs BHC (13.39). AMRX YTD gains are higher at: -1.389 vs. BHC (-29.653). BHC has higher annual earnings (EBITDA): 2.2B vs. AMRX (400M). BHC has more cash in the bank: 947M vs. AMRX (91.5M). AMRX has less debt than BHC: AMRX (2.75B) vs BHC (22.4B). BHC has higher revenues than AMRX: BHC (8.76B) vs AMRX (2.39B).
AMRXBHCAMRX / BHC
Capitalization1.87B3.86B48%
EBITDA400M2.2B18%
Gain YTD-1.389-29.6535%
P/E Ratio90.0013.39672%
Revenue2.39B8.76B27%
Total Cash91.5M947M10%
Total Debt2.75B22.4B12%
FUNDAMENTALS RATINGS
AMRX vs BHC: Fundamental Ratings
AMRX
BHC
OUTLOOK RATING
1..100
6769
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
43100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5086
P/E GROWTH RATING
1..100
2197
SEASONALITY SCORE
1..100
42n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (32) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (95) in the Pharmaceuticals Major industry. This means that BHC’s stock grew somewhat faster than AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for BHC (100) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than BHC’s over the last 12 months.

AMRX's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to BHC’s over the last 12 months.

AMRX's Price Growth Rating (50) in the Pharmaceuticals Major industry is somewhat better than the same rating for BHC (86) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than BHC’s over the last 12 months.

AMRX's P/E Growth Rating (21) in the Pharmaceuticals Major industry is significantly better than the same rating for BHC (97) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew significantly faster than BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXBHC
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VFL10.350.10
+0.93%
abrdn National Municipal Income Fund
SAT24.580.08
+0.33%
Saratoga Investment Corp
EMCR29.11-0.59
-1.99%
Xtrackers EM CarbReduc&ClimtImprvs ETF
QSPT25.78-1.02
-3.80%
FT Vest Nasdaq-100® Buffer ETF Sep
BSVO18.20-1.52
-7.71%
EA Bridgeway Omni Small-Cap Value ETF

AMRX and

Correlation & Price change

A.I.dvisor tells us that AMRX and HROW have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMRX and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-4.41%
HROW - AMRX
32%
Poorly correlated
-7.64%
CRON - AMRX
32%
Poorly correlated
-1.66%
EBS - AMRX
32%
Poorly correlated
-6.58%
ORGO - AMRX
30%
Poorly correlated
-6.44%
VRNOF - AMRX
30%
Poorly correlated
-3.74%
More